Tvardi Therapeutics, Inc. Common Stock Shares Outstanding

Quick Answer

Tvardi Therapeutics, Inc. reported Common Stock Shares Outstanding of 9.38 million shares for the year ending 2025.

  • Tvardi Therapeutics, Inc. showed an increase of +264.4% in Common Stock Shares Outstanding from 2024 to 2025.
  • This data is from Tvardi Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
  • XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 13 years of available data (2013 to 2025), Tvardi Therapeutics, Inc.'s Common Stock Shares Outstanding has grown by 118.8%.
  • Historical annual values: Fiscal year 2025: 9.38 million shares | Fiscal year 2024: 2.57 million shares | Fiscal year 2023: 4.54 million shares | Fiscal year 2022: 53.80 million shares | Fiscal year 2021: 53.48 million shares | Fiscal year 2020: 49.87 million shares | Fiscal year 2019: 46.72 million shares | Fiscal year 2018: 39.55 million shares | Fiscal year 2017: 32.66 million shares | Fiscal year 2016: 27.30 million shares | Fiscal year 2015: 27.25 million shares | Fiscal year 2014: 22.80 million shares | Fiscal year 2013: 4.29 million shares.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: